serving better health information
HRT increases ovarian cancer risk
Ovarian Cancer :: HRT increases ovarian cancer risk
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
Results from the Million Women Study, which is the biggest study of its kind in the world, show that over five years there is one extra case of ovarian cancer in every 2,500 women who take HRT. And for every 3,300 women who take HRT, there will be one additional death from ovarian cancer.
The researchers, who are largely funded by Cancer Research UK, estimate that use of HRT since 1991 has resulted in an extra 1,300 cases and 1,000 deaths from ovarian cancer.
The study also suggests that a woman?s risk of ovarian cancer returns to a normal level within a few years of stopping HRT.
Ovarian cancer is the fourth most common cancer in women in the UK with almost 7,000 new cases each year. The five year survival rate for the disease is less than 30 per cent which reflects the fact that ovarian cancer is often diagnosed at a late stage.
Lead researcher, Professor Valerie Beral director of Cancer Research UK?s epidemiology unit at the University of Oxford, said: ?The results of this study are worrying because they show that not only does HRT increase the risk of getting ovarian cancer, it also increases a woman?s risk of dying of ovarian cancer.
This study, along with our previous research, clearly demonstrates the cancer risks of taking HRT.
»» Obesity :: School playgrounds can help fight childhood obesity
«« Health Insurance :: New health insurance survey - Women have trouble affording care needed
www.spiritindia.com - About us, Editorial Team, Authors, Testimonials, Linking us, Advertising, Advertisers, Recommend us, Feedback, Privacy policy, Disclaimer, Feedback
©2002-2008 SpiritIndia Group